CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$4.52
0.04 (0.89%)
▲
5d:
-1.31%
30d:
+2.49%
90d:
-10.5%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CTKB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: CTKB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $4.52, which is considered slightly high relative to its 30-day fair value range of $4.21 to $4.54. The stock's valuation (Forward PE: 99.6) is in line with its historical norms (92.8). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CTKB is in a strong downtrend. Immediate support is located at $4.19, while resistance sits at $4.75.
Market Sentiment: CTKB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+33.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTKB is in a strong downtrend. Immediate support is located at $4.19, while resistance sits at $4.75.
Market Sentiment: CTKB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+33.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$4.21 -
$4.54
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.9% below Wall St target ($6.00)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$4.21 -
$4.54
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.19
Resistance Level
$4.75
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
99.56
Wall Street Target
$6.00
(+33.9%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
73.5%
Profit Margin
-33.0%
Valuation Premium vs History
+2.4% premium
PE vs Historical
99.6 vs 92.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$4.59
(+2%)
2-Year Target
$4.70
(+5%)
3-Year Target
$4.81
(+7%)
3-Yr Target (if PE normalizes)
(PE: 100→93)
PE COMPRESSION
$4.48
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: April 02, 2026 12:35 PM ET
Data refreshes hourly during market hours. Next update: 1:35 PM
Data refreshes hourly during market hours. Next update: 1:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 59 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 65 BUY |
